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1. Introduction 
Food poisoning caused by Salmonella enterica serovar enteritidis (SE) became a major public 
health problem in the middle of the 1980s, and several years were required to identify that 
the main causative food material was chicken eggs (Altekruse S. et al. 1993, a),b)CDC 1990, 
Cogan TA et al., Cowden JM et al. 1989, Henzeler DJ et al. 1994, Humphrey TJ 1994, 
Kusunoki J et al. 1996, Lin FY et al. 1988, Shivaprad HL et al. 1990, St Louis ME et al. 1988). 
Since CDC had firstly-reported the main causative origin of SE food born disease being shell 
eggs (CDC. 1987), shell eggs as a causative food have attended (Hogue A. et al. 1997, 
Humphrey TJ et al. 1991, Rodrigue DC et al. 1990,). World status of SE outbreaks at around 
1999 is well-reviewed in the book of “Salmonella enterica serovar enteritidis in human and 
animals”. (Saeed AM. Ed. 1999. Iowa State University Press). SE-contaminated chicken eggs 
are indistinguishable from non-contaminated eggs in appearance. As the sensory 
elimination of SE-contaminated chicken eggs was shown to be impossible, greater 
importance has been attached to the control of SE contamination in the egg production step 
(a),b)CDC 1990, Okamura M et al. 2001, Rodrigue DC et al. 1990, and Stevens A et al. 1989, 
Thomas RD 1989). The development of live and inactivated SE vaccines has been 
investigated because SE contamination of chicken eggs remained even after various hygienic 
countermeasures were taken on layer farms, and SE vaccine administration was started in 
the 1990s in Western countries. However, SE vaccines have only recently been recognized as 
an important tool to reduce SE-contaminated chicken egg production on layer farms. 
Regarding efficacy evaluation of SE vaccines, the effect of live SE vaccine was understood as 
competitive elimination (Barrow PA et al. 1991, Hassan JO et al. 1997, Nasser TJ et al. 1994, and 
Parker C 2001), but many questions remained regarding inactivated SE vaccine (Davies R et al. 
2003, Gast RK et al. 1992, Okamura M et al. 2007). The question concerning efficacy was 
whether the vaccine can eliminate SE which colonizes the digestive tract and reproductive 
organs even after elevating resistance in blood and parenchymal organs by SE antigen 
inoculation. For example, 100% elimination of gastrointestinal SE could not be achieved 
immediately after challenge in the chickens administrated with an inactivated SE vaccine, and 
also orally ingested bacteria proliferated in the gastrointestine. Moreover, concerning the 
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mode of infection of pullorum disease (Salmonella enterica serovar pullorum infection) in 
chickens as a model (Gwatkin R. 1948, Shivaprasad HL. 2000), SE infection normally manifests 
no clinical symptoms and natural resistance levels rise in chickens aged 3 weeks or older, at 
which time inactivated SE vaccine becomes administrable, and SE colonization in the 
gastrointestine is very limited. Accordingly, it was considered that inactivated SE vaccine is 
unnecessary for chickens aged 3 weeks or older because of enhanced resistance to SE infection 
and the effect of inactivated SE vaccine is not useful. However, considering that the ultimate 
objective of inactivated SE vaccine administration to chicken flocks is to reduce SE-
contaminated chicken egg production, we performed studies assuming that SE contamination 
of chicken eggs can be prevented by employing inactivated SE vaccine through a mechanism 
different from those of vaccines preventing chicken diseases, and epidemiologically clarified 
that inactivated SE vaccine administration in layer farms reduced the number of SE-
contaminated chicken eggs to 1/260 and the isolation frequency to 1/10 as shown in Table 1 
(Summary of field study on SE isolation incidence and bacterial No. in the presence and 
absence of SE bacterin application in four layer farms. a)Toyota-Hanatani Y et al. 2009). We also 
confirmed a high epidemiological risk-reducing effect of inactivated SE vaccine administration 
to flocks. Furthermore, we investigated the active component of inactivated SE vaccine and 
identified that the important activity is located at the flagellar g.m. antigen site (SEp 9) and the 
other components do not induce potent specific antibody production.  
Incidence/Percentage 
Vaccination status 
with inactivated 
SE vaccine 
Result 
bacterial No. or 
Mean 
(MPN/100mL) 
±SE a) 
Bacterial No. Yes <2 to <8 2.5±0.1** 
 No <2 to >1,600 674±4.1 
Incidence Yes 14/571 2.45%** 
 No 10/40 25% 
**p<0.01 a) Mean ± Standard error  
Table 1. Summary of field study on SE isolation incidence and bacterial No. in the presence 
and absence of SE bacterin application in four layer farms. (a)Toyota-Hanatani Y 2009. et al.) 
This table summarizes SE detection using more than 20 kg of liquid egg in four laying 
houses where inactivated SE-vaccinated and -unvaccinated chickens were housed for three 
years. As shown in this table, SE was isolated at up to 8 MPN (Most Probable Number) per 
100 ml from inactivated SE-vaccinated chickens and over 1,600 per 100 ml from some non-
vaccinated flocks. The inactivated SE vaccine significantly reduced public health risks. 
Material and Method; Four layer farms were monitored using over 20 kg liquid eggs for 3 
years according to the method described in Fig. 1. In this duration, the vaccination status 
with SE bacterin was mixed (Vaccinated and un-vaccinated flocks were there in each farms). 
In previous studies on the mode of SE infection in flocks, the mode of infection of pullorum 
disease (PD) bacteria in chickens (Table 2. Mode of SE infection in chickens and chicken 
flocks) was referred to and investigated as a model in the SE vaccine development. 
However, a recent study and our survey results suggested that SE contamination/infection 
of chickens disseminates through mouse-mediated transmission between hen houses 
(Davies RH et al. 1995, Henzler DJ et al. 1992), and not by vertical infection as in PD 
infection model (Yamane Y et al. 2000). Unlike SE infection of mice and humans (Guiney DG 
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et al. 1995), SE infection of individual chickens occurs as opportunistic infection excluding 
that immediately after hatching (a),b)Bohez L et al. 2007, and 2008, Dhillion AS et al. 2001, 
and Roy TP et al. 2001), and the infection is not systemic and manifests no symptoms in 
infected chickens. Based on previous study results reported, it is suggestive that SE ingested 
by a chicken evades the chicken’s immune system by changing substances expressed on its 
surface, which may be the essence of Salmonella infection 
Mode of infection Concept of mode Examples and explanations 
1. Vertical transmission 
 
 
 
 
In chicks SE Infection 
occurred from infected parent 
chickens via embryonated  
eggs. 
PEQAP research data  
said this mode infection  
might be positioned at less 
than 5 % in all the infection 
cases in chicken flocks. 
Infection mode of pullorum 
disease(PD) in chickens (PD 
is asymptomatic in adult 
chickens, but is highly lethal 
in chicks.) Thus, an antibody 
test was conducted in adult 
chickens to successfully 
eradicate positive ones. 
2. Horizontal infection  
 
 
 
Between chicken flocks 
(This route is more common 
according to the PEQAP 
survey) 
Common route 
(SE may be transmitted by 
mice.) 
Table 2. Mode of SE infection in chickens and chicken flocks. (Summarized by Ohta H)At 
first, many poultry farmers considered that SE was vertically transmitted. This is because 
both Salmonella pullorum and SE carry O9, O12, and O1 (belong to Salmonella D group and 
have the same antigenicity except for the presence of flagellar antigen) as bacterial antigens. 
Thus, many poultry farmers had tried that they could take measures by conducting a SE 
contamination (antibody) survey in breeding chickens to remove positive chickens. 
However, the PEQAP and our surveys demonstrated that SE infection was transmitted 
among laying flocks and that contamination was limited in growing and breeding farms. 
Thus, we considered that the inactivated SE vaccine might be effective. 
2. Historical changes in the concept of ‘food safety’ with the recent 
emergence of SE food poisoning  
2.1 History of occurrence of SE-contaminated chicken egg-induced SE food 
poisoning 
Outbreaks of SE food poisoning, not previously noted, frequently occurred worldwide after 
1980, mainly in Western countries, and became a social problem (Davison S et al. 2003, 
Stevens A et al. 1989). Before 1980, Salmonella food poisoning was mainly caused by 
Salmonella enterica serovar Typhimurium (ST), and so this species was mainly studied. 
Countermeasures against ST-induced food poisoning were taken to avoid hygiene problems 
of cooking facilities in many cases, and actions rarely reached the management of food 
material production. However, outbreaks of SE-induced food poisoning occurred in the 
middle of the 1980s in Western countries, and studies and study result-based 
countermeasures for not only ST but also SE food poisoning became necessary. The most 
surprising evidence with SE outbreaks for epidemiologists is that the outbreaks are 
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sometimes caused with several number of SE not caused with numerous SE (Foley SL et al. 
2008). At the beginning, contaminated food products and materials in SE food poisoning 
were unclear, and actions were mainly taken involving only cooking facilities, similarly to 
measures taken for ST. Many cooking facilities tried to eliminate ‘inappropriate food 
materials (food materials detectable by sensory evaluation, such as those which had started 
decomposition and color change)’, and complete hygiene measures were taken at cooking 
facilities. However, the occurrence of SE food poisoning did not stop. Around the end of the 
1980s, researchers started to point out that chicken eggs were very likely to be contaminated 
by SE (a),b)CDC 1990, Rodrigue DC et al. 1990, Steven A et al. 1989, Thomas RD 1989). In 
poultry industry in United Kingdom, a poultry association consisting of eggs producers, 
feed suppliers, eggs traders, egg-packing sections joined together to establish an egg 
sanitary standard like as HACCP (Hazard analysis and critical control point) system, so 
called Red Lion Code. On the other hand, SE-contaminated chicken eggs were vigorously 
studied, and several tens of thousands of chicken eggs were individually tested for SE 
contamination, and the incident of SE contamination eggs originated from SE infected 
poultry flocks also reported to be about 10 folds increasing compared with those of ordinary 
shell eggs (Humphrey TJ et al. 1994). In the U.S., it has been said that several million chicken 
eggs were individually tested for SE. These are unbelievable numbers compared to that in 
the current SE test, and our studies are based on the efforts of researchers at that time, to 
which I express my respect.  
2.2 Why did SE-contaminated chicken eggs become a public health issue?  
Since very few chicken eggs on layer farms are contaminated, reportedly, several in 10,000 
eggs, SE-contaminated chicken eggs were not recognized as the cause of SE food poisoning 
earlier, as described above. However, many retroactive surveys suggested that the main 
cause was chicken egg-mediated SE contamination. On the other hand, layer farm-related 
test facilities performed SE tests based on the mode of PD infection as the model, and this 
was mainly performed for breeding flocks and chicks. Nearly 100% of samples from layer 
breeder farms were negative, and the isolation rate from breeding flocks and just hatched 
chicks was not high enough to explain the occurrence of SE food poisoning in humans. It 
was revealed that growing chickens and chicks are rarely contaminated with SE, which was 
markedly different from the retroactive survey results of food poisoning. Accordingly, 
chicken egg producers and chicken salmonellosis researchers believed that the frequency of 
SE-contaminated chicken eggs is very low, SE contamination of eggs on layer farms is not 
the main cause, and food poisoning occurs due to SE contamination of chicken eggs during 
distribution or at the consumer level due to inappropriate classic hygiene management. The 
detection and removal of SE-contaminated chicken eggs by employing sensory tests were 
considered possible at that time, and some people strongly believed that detection and 
removal at cooking facilities using the conventional method were possible. However, many 
retroactive surveys (Fris C et al. 1995, Henzler DJ et al. 1994, Kusunoki J et al. 1996) revealed 
that SE contamination was present in eggs that appeared normal as well as on layer farms, 
which led to recognizing that measures to reduce SE-contaminated chicken eggs are 
necessary and the safety control of food products and materials should be facilitated by 
producers, distributors, and consumers in unity. However, considerable time was necessary 
to spread the necessity of taking actions to reduce SE-contaminated chicken egg production 
to people related to chicken egg production.  
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1. Characteristics of farms with frequent SE contamination 
1. Large scale (many chickens) 
2. Many mice 
3. Multiage flocks 
4. Many poultry houses 
5. EP center established side by side 
2. Age (days) when SE infection occurs more commonly 
1. After transfer to egg collection poultry farm and during laying peak (170-200 days 
old) 
2. After laying peak 
3. Newborn to 10 days old 
4. 10 days old to transfer to egg collection poultry farm (in rare cases) 
*Most SE infections occur in 1) and 2). 
Table 3. Characteristics of SE infection in layer flocks (Biomune's seminar on SE vaccine in 
Japan in 1996, based on PEQAP research data) 
In the northeastern U.S., severe SE contamination occurred in the latter half of the 1980s. Thus, 
egg consumption markedly decreased because of harmful rumors among consumers. Poultry 
farm associations, Pennsylvania government, U.S. federal government, etc. established the 
Pennsylvania Egg Quality Assurance Program (PEQAP) to survey SE contamination in egg-
collecting farms in Pennsylvania. In addition, SE contamination rates of eggs and measures, 
such as inactivated SE vaccine, were evaluated. As shown in this table, SE infection spread in 
egg-collecting farms, in which mice played an important role. In addition, the inactivated SE 
vaccine reduced SE-contaminated eggs, but did not effectively eradicate them. 
In the 1980s to early 1990s, chicken eggs were reported to be the main cause of SE food 
poisoning by various media, resulting in a marked reduction of chicken egg consumption. The 
SE issue put chicken eggs in a disadvantageous sales situation: egg consumption decreased not 
due to the reports of scientists, but because consumers and egg sellers (supermarkets) 
considered that eggs were produced by large layer farms performing no hygiene control. 
Layer farms in North East America, and England and Wales specified as SE-contaminated 
regions instantaneously lost more than 50% of chicken egg consumption, so-called ‘damage 
caused by harmful rumors’ (Davison S et al. 2003). The layer farm industry and instructing 
administrative agency were surprised and started joint studies involving layer farms, 
universities, and related administrative agencies. Based on the study results, the 
administrative agency adopted various measures for chicken egg production and distribution 
including legal action. For example, in response to this situation, Pennsylvania State in the U.S. 
vigorously surveyed the actual state of SE contamination on layer farms, investigated the 
mode of SE contamination, and evaluated various countermeasures. The survey results of the 
Pennsylvania Project (PEQAP) concerning the mode of SE infection of chickens (Hogue A et al. 
1997) revealed that no SE infection was observed in chickens in the growing period, and most 
cases of infection occurred after chicks were introduced into layer hen houses (Table 3. 
Characteristics of SE infection in layer flocks unpublished data). The point emphasized was 
the presence of mice playing an important role in SE transmission between hen houses as 
above mentioned. Based on these epidemiological study findings, the U.S. government took 
administrative action by establishing a law which allows selling only sterilized egg liquid 
prepared from eggs collected from SE-contaminated hen houses (Table 4 US-FDA egg safety 
rule; US Federal Register 2009. 74: 33030-330101.). In Japan, labeling chicken eggs sold in 
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packages with a date (laid, packaged, or sell-by date) is required. Administrative actions have 
been taken against SE food poisoning in many countries. In which “Red Lion Code” is 
involved. The history of the recent emergence of SE food poisoning emphasized the necessity 
of analyzing the cause of food poisoning in the processes of chicken egg production through 
distribution and consumption (Schroeder CM et al. 2006). For analysis and the control of 
health damage risks of not only chicken eggs but also all food products, identification and 
evaluation of possible risks in each step of production, distribution, and consumption and 
investigation of countermeasures while considering the cost-effectiveness have been 
established as “ risk analysis concept” and applied to the problem of SE-contaminated chicken 
eggs as one case. However, no basic concept for the control of bacterial food poisoning has 
been established, and many epidemiological studies are still necessary.  
Testing or Procedure FDA 
Chicks NPIP SE Clean breeders 
Pullet testing 14 to 16 weeks 
Requirement for pullet + manure 
Egg testing of 4 sets of 1000 eggs at 2 week 
intervals 
Layer testing  40w and 4-6 weeks after molt completion 
Egg testing if manure positive 1000 eggs at 2 week intervals, 4 submissions 
Diversion to pasteurization required for egg+ 
flocks 
Yes 
Return to shell market allowed 
Yes after a completed set of 4 submissions of  
1000 eggs every 2 weeks 
Egg testing after initial egg test set 
None if negative first set; once a month if 
were previously egg positive 
C&D of manure or egg + houses Wet or dry cleaning 
Vaccination required None 
Biosecurity plan Required 
Rodent Control Plan and Records Required 
Fly Control Plan and Records Required 
(personal information from Dr. Lozano F)  
Table 4. US-FDA egg safety rule (Established by USDA, 2009) 
2.3 History of SE vaccine 
Live ST vaccine was used as SE control in large-scale state layer farms in Former Eastern 
Europe before the reunification of East and West Germany as described below. The safety 
and efficacy of this live ST vaccine for SE control were investigated, and several 
preparations are still used now.  
Regarding inactivated SE vaccine, I would like to introduce the history of its first appearance 
in the world. The in-house vaccine system was established in the U.S. in the 1980s. In this 
system, farms which isolated the pathogen were allowed to use an inactivated vaccine for the 
infectious disease not included in highly pathogenic infectious diseases of animals, such as 
legal infectious diseases, and approval was granted to in-houses vaccine manufacturers. An in-
house vaccine manufacturer produced a vaccine using an SE strain isolated from a layer farm, 
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and the vaccine reduced the SE isolation frequency on the farm. This was the first preparation 
of inactivated SE vaccine. The world’s first state approval was granted for a vaccine which 
showed efficacy in the field, not prepared through establishing an evaluation method in a 
laboratory and then confirming the efficacy in the field. Subsequently developed inactivated 
SE vaccines were produced following the first inactivated SE vaccine as the standard.  
3. Discussion on the usefulness of SE vaccine administration to chickens 
3.1 Situation at the time of early approval of inactivated SE vaccine  
The world’s first approval of inactivated SE vaccine by the administrative authority was 
granted to Layermune SE (Biomune Co., Kansas) in the U.S.A. in 1992. Since then, inactivated 
SE vaccine has been discussed with regard to not only the efficacy but also many other aspects. 
Discussions have mainly concerned doubt regarding the efficacy, and, secondly, vagueness of 
the objective of use. Generally, the objective of animal and human vaccines is the prevention of 
clinical problems of vaccinated animals and humans, but SE infection manifests no clinical 
symptoms in chickens excluding newborn chicks, causing no economic damage. For newborn 
chicks, there is no time for vaccination because infection occurs before inactivated SE vaccine 
exhibits an immunological effect. Accordingly, inactivated SE vaccine is administered to 
chickens developing no clinical problems, and the objective is only to reduce the public health 
risk (reduction of SE-infected chicken egg production). Chickens are vaccinated for a disease 
manifesting no clinical symptoms, but the effect of the vaccine has to be investigated in these 
chickens. Economically, inactivated SE vaccine has to be administered to individual chickens, 
requiring considerable human labor and expense for purchasing the vaccine. Since SE infection 
causes no direct economic damage, vaccine administration to chickens on farms requires the 
high-level motivation of vaccine users. The first inactivated SE vaccine was a new type of 
vaccine, i.e., emergence of a high-cost vaccine slightly stressful to vaccinated animals and not 
preventing disease in the animals white leghorn chickens (Mizumoto N et al. 2004).  
We also investigated the efficacy of inactivated SE vaccine employing various challenge 
tests. In one of the tests, SE was orally challenged 3 or 4 weeks after inactivated SE vaccine 
administration, and SE was re-isolated from the gastrointestine and parenchymal organs. 
Concretely, 3-week-old SPF chickens were vaccinated at the normal dose and orally 
challenged with food poisoning-derived SE at a high bacterial count after 4 weeks (at 7 
weeks of age), and the bacteria were re-isolated from the cecum after 1-7 days. SE was 
isolated from nearly 100% of chickens despite the vaccine having been administered. When 
the number of challenged bacteria was reduced to a moderate count, the number of isolated 
bacteria was significantly decreased in many animals in the vaccinated group, but the 
results were not stable. In chickens subjected to the test at 5 or 7 weeks of age, the isolation 
frequency after challenge (at 11 weeks of age) was markedly lower in the control non-
vaccinated group. Accordingly, a large number of chickens are necessary to perform the 
challenge test at this age, which is not routinely possible. In this laboratory test, a significant 
reduction of the intestinal bacterial count was observed, but complete disappearance of the 
bacteria from the gastrointestine has not been confirmed within a couple of weeks.  
3.2 Situation at the time of the initiation of our study  
In 1990, we were informed of SE-contaminated chicken egg production on layer farms 
covered by our veterinary care activity. We administered bacteriostatics and organic acids 
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on large-scale layer farms, hoping to avoid a decline in consumption, which occurred in 
America and England, but no effect was obtained. Thus, we performed a field 
epidemiological study of the efficacy of inactivated SE vaccine (Yamane Y et al. 2000). 
Inactivated SE vaccine was administered to flocks on a large-scale layer farm with apparent 
SE contamination. Eggs (500 kg) were broken in a liquid egg plant, 1,000 ml was sampled 
from the liquid egg batch, and 400 ml was subjected to SE isolation. The isolation rate was 
compared between the vaccinated and non-vaccinated groups. The results are shown in Fig. 
1. (Fig. 1 Number of SE isolates and SE isolation frequency of SE-contaminated chickens and 
inactivated SE-vaccinated chickens in the same poultry house). Furthermore, our study 
confirmed horizontal infection of 4 industrial poultry farms (Table 5. SE samples monitored 
and their results with 4 integrated layer companies (1996-1998)). Based on those results, it 
was considered necessary for the positivity rate on plate agglutination with pullorum 
disease-diagnostic antigen to be 90% or higher in the SE-inoculated group (0% in the non-
inoculated control group), while vaccination of SE-contaminated farms significantly reduced 
the number of bacteria isolated from liquid egg samples from 500 kg or more of eggs 
compared to that from non-vaccinated chickens (Table 6 Evaluation criteria for the 
inactivated SE vaccine (Layermune SE) in field chickens). In addition, the requirement of the 
number of isolated bacteria from chicken feces was set at 1 CFU or lower per 1 g in the 
inactivated SE vaccine-treated group. Later, similar results were obtained in the test using 20 
kg of eggs (about 320 eggs). We partially demonstrated these established values 
epidemiologically after more than 10 years (a)Toyota-Hanatani Y et al 2009).  
Vertical section 
for SE monitor 
Sample materials 
Result 
monitored 
Memo 
Breeder farms 
 
 
 
 
(Hatchery)  
1) Several swabs 
2) Manure 
3) Sera to detect 
antibody   
4) Workers feces   
1) Swab 
2) Worker feces 
No detection 
at all 
 
 
 
No detection 
 
 
Using SE cell 
antigen coated 
ELISA 
Feed mile  Any protein source No detection   
Growing  Like as breeder No detection  
Laying  1) Swabs 
2) Manure  
3) Dusts 
4) Liquid eggs 
5) Workers feces 
6) Water in EP 
center 
No detection 
A few positive 
A few positive 
Several positive 
No detection 
Detectable 
 
Table 5. SE samples monitored and their results with 4 integrated layer companies (1996-
1998) (Yamane Y et al. 2000. modified). Our severance studies (Yamane Y et al. 2000) 
summarizes the results of SE tests conducted in breeding farms, feed mills, and EP centers 
for three years. As shown in this table, no vertical transmission (infection from laying to 
adult chickens) occurred. The infection was repeated within a laying poultry houses. 
Materials and Methods; See Fig. 1. 
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Case 1  Case 2 
  Age SE(MPN) ELISAC  Age SE(MPN) ELISA 
Year1 Jan. 237 ○ 0 %  181   
  260 ○   252 ●( >1600) 0 % 
    0 %     
  350 ○      
         
    0 %    45 % 
 Jul.   20 %  349 ●(NT)  
  455 ●(NT) 20 %    28 % 
        35 % 
      447 ●(NT)  
         
  552 ●(39) 15 %    20 % 
Year2 Jan.        
    35 %    25 % 
         
    25 %    10 % 
    25 %     
    40 %     
 Jul.     729 Replaced  
  881 娟      
  911 ▲ 35 %     
      218 娟  
  937 Replaced   245 (<2)  
      259 娟  
Year3 Jan.        
  168 娟   316 娟  
         
  239 娟   386 娟  
         
  302 娟      
      435 娟  
Fig. 1. Number of SE isolates and SE isolation frequency of SE-contaminated chickens and 
inactivated SE-vaccinated chickens in the same poultry house (Yamane Y et al. 2000) 
SE isolation in field chickens before and after inoculation of the inactivated SE vaccine 
(Layermune SE) (Four cases are shown in the reference. Two cases are shown here.) (Filled 
circles indicate SE isolation). The number indicates the number in ( ) of SE isolates. 
The detection rates of SE antibodies in unvaccinated chickens by ELISA coated with SE cell 
antigen was 0-40% for Case 1 and 0-45% for Case 2. To our experiences, the antibody 
positive rate of 400-500-day-old chickens inoculated with the inactivated SE vaccine (at 300-
400 days after vaccination) was about 70-100%. Inaccurate administration of SE bacterin may 
induce the antibody positive rate of inactivated vaccine to be further decreased. Thus, 
vaccination and field infection cannot be distinguished at antibody level. The number and 
frequency of SE isolates decreased in the vaccinated group. 
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Material &Methods: An industrial layer farm was monitored. SE isolation was done using 
liquid eggs samples originating from 500 kg of shell eggs. And then most probable number 
(MPN) per 100 m was determined. For detection of specific antibody in the sera of the flocks, 
an ELISA coated with SE cell antigen was used. 
Test item Method Procedures Criteria 
Antibody 
response 
RPA 
Twenty chickens were 
examined at 4 weeks 
after vaccination. 
≥90%: Markedly 
effective 
<90%~≥80%: Effective 
<80%: Non effective 
Antibody 
response 
ELISA Same as above Same as above 
Bacterial 
isolation 
Bacterial 
isolation 
500 kg of eggs are 
collected from the 
vaccinated group. The 
eggs are broken and 
cultured within 48 
hours after collection. 
≤10MPN/100mL: 
Markedly effective 
(if materials from the 
unvaccinated group of 
the same farm showed 
≥1,600 MPN/100 mL) 
Table 6. Evaluation criteria for the inactivated SE vaccine (Layermune SE) in field chickens 
(application form for the reexamination of this formulation in Japan, provided by CAF 
Laboratories) 
The effectiveness of the formulation (Layermune SE) in Japan is evaluated based on this 
table. The formulation was effective in all the 12 chicken groups by an antibody test. 
However, SE-contaminated farms could not be surveyed by bacterial isolation. 
3.3 Risk of misjudging inactivated SE vaccine-treated chickens as SE-infected 
chickens  
We had a problem in handling inactivated SE vaccine in our field facilities: inactivated SE 
vaccine-treated chickens and SE-infected chickens showed the same serological reaction 
(Table 7. Production of antibodies against SE bacterial antigens in inactivated SE-
vaccinated and -unvaccinated chickens). Inactivated SE vaccine is generally administered 
at about 80 days of age. In chickens treated with a commercial inactivated SE vaccine, the 
anti-bacterial cell antigen-antibody positive rate determined using commercial antigen 
solution for the diagnosis of PD, or SE cell antigen coated ELISA reaches nearly 100% 
within about 120 days of age and then slowly decreases and reaches 20-60% at about 300 
days of age, whereas the positive rate in SE-infected chickens is about 5-70%. We 
attempted to distinguish SE-infected from inactivated SE vaccine-treated chickens because 
eggs laid by inactivated SE vaccine-treated chickens are misjudged as those laid by SE-
infected chickens, if the 2 chicken groups of SE infected and vaccinated cannot be 
distinguished. Thus, we investigated specific antibodies present only in chickens with 
‘inactivated SE vaccine treatment’ described below (Fig. 4. Detection of specific antibodies 
in sera against SE cell antigen and SEp9 on oral SE administration to field white leghorn 
chickens) (Mizumoto N et al. 2004).  
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Group Positive rate (references) Test methods** (References) 
Inactivated SE 
vaccine 
In the laboratory  
 
In field  
 
Vaccination 
At 30-40 dpv: 95-100% 
                       : ≥ 90% 
300~400 days old: 70~100% 
 
ELISA 
RPA 
 
ELISA 
 
SE infected group 
(Field group) 
Shipping to slaughterhouse 
(about 700 days old): 0-15% 
Induced molting 
(400-500 days old): 0~45% 
ELISA 
 
 
ELISA 
(Mizumoto N  
et al. 2004, 
Sunagawa H et al. 
1997, Yamane Y  
et al. 2000) 
* Age of vaccination: around 80 days old  
** ELISA: Indirect method with SE cell antigen coated.  
RPA: rapid plate agglutination with diagnostic for pullorum disease antigen. 
Table 7. Production of antibodies against SE bacterial antigens in inactivated SE-vaccinated 
and -unvaccinated chickens (summarized by our research group) 
Almost all the 3-week-old or older chickens inoculated with the inactivated SE vaccine were 
positive at around four weeks by both ELISA (coated with SE cell antigen) and RPA. 
Subsequently, the positive rate decreased at 250 days or later after inoculation. The positive 
rate in the ELISA coated with the g.m. antigen of SE was shown above 80% up to about 700 
days old. On the other hand, SE-contaminated chickens showed the similar positive rates as 
those of inactivated SE-vaccinated chickens in ELISA coated with SE bacterial antigen and 
RPA. Generally, the positive rate of SE-contaminated chickens is lower than that of 
inactivated SE-vaccinated chickens. However, an antibody test cannot distinguish these 2 
groups, because some SE-contaminated chickens show higher positive rate. 
3.4 Active component of inactivated SE vaccine (main Fli C antigen: SEp 9)  
Using sera from inactivated SE vaccine-treated and SE-infected chickens, we compared the 
production of antibodies against the SE cell antigen to investigate differences between the sera. 
A strong reaction with a 53-kDa polypeptide (Fli C) (Namba K et al. 1997) was observed in all 
serum samples from inactivated SE vaccine-treated chickens, but rare reaction with a specific 
antigen was noted in SE-infected chicken-derived serum samples (Fig. 2. Western blotting with 
sera from SE-infected and inactivated SE-vaccinated chickens using formalin-treated SE 
antigens (surface antigens)). Fli C is considered to be strongly antigenic as inactivated SE 
vaccine. When the SE-specific polypeptide (g.m. antigen) in Fli C (Van Asten AJ et al. 1995, and 
Yap LF et al. 2001) was prepared by genetic engineering and reacted with serum from 
inactivated SE vaccine (Layermune SE)-treated chickens, strong reactivity was noted, but SE-
infected chicken-derived serum did not react with g.m. antigen. When the specific antibody 
reaction was investigated in sera from chickens treated with other vaccines sold in Japan (oil 
adjuvant vaccine 3 and aluminum hydroxide gel vaccine 1), a specific antibody reaction with 
g.m. antigen was noted in the serum of oil adjuvant vaccine-treated chickens (Fig. 3. 
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Production of specific antibodies against commercial inactivated SE vaccines SE cell and SEp9 
antigens). In an experiment, the inoculated chickens with SE induces antibody against SE cell 
antigen but not SEp 9. In field poultry flocks, inactivated SE vaccine administration was 
confirmed a long period persistency of specific antibody level against SEp 9 until 700 days of 
age (Fig. 5. Positive rates of g.m.-specific antibodies in the yolks derived from field chickens 
inoculated with the inactivated SE vaccine).  
   
(a)      (b) 
Fig. 2. Western blotting with sera from SE-infected and inactivated SE-vaccinated chickens 
using formalin-treated SE antigen (surface antigen) (Nakagawa Y et al. reported by Japanese) 
Figure 2a shows the reactivity of sera from 3-week-old SPF chickens which received oral SE 
administration (C1~9, M: marker protein), examined by Western blotting (SDS-PAGE) with SE 
surface antigen. Fig. 2b shows Western blotting with the same antigen using sera from 3-week-
old SPF chickens inoculated with the inactivated SE vaccine (Layermune SE) (at 4 weeks after 
inoculation) (V1~3) or from those from which SE was isolated from naturally-infected-field 
flocks (N1~5; 710 days old). 
Fig. 2a shows that light antibody response against 53 kDa (Fli C of SE) was noted in two 
chickens (one chicken at 2 weeks) and no band against Fli C (53 kDa polypeptide) was noted in 
all the nine SE-intraoral inoculated chickens. As shown this figure, one of 2 responded band at 
week post inoculation (wpi) was continued by 2 wpi but not by 4 wpi. Thus, the responsive 
antibody was considered to be IgM antibody. In another our report, a 53 kDa band was not 
detected in 4-week-old SPF chickens and 300-day-old field chickens, which received SE 
administration, but was detected in molting-induced chickens (Mizumoto N et al. 2004, Piao Z 
et al. 2007). Thus, the antibody against the 53 kDa polypeptide after SE inoculation is 
suspected no invasion into the internal organs. 
Fig. 2b shows strong bands against the 53 kDa polypeptides and its dimer (98 kDa) in 
inactivate SE-vaccinated chickens. However, in chickens from which SE could be isolated, a 
weak band could be detected at around 42 kDa, but no band could be detected at 53 kDa. 
Materials and Methods: For antigen preparation, SE was treated with formalin and centrifuged 
at 2000 g for 20 min. Then the supernatant was further centrifuged at 10,000g for 60 min and 
the precipitate dissolved in a buffered saline. The antigen was used in this analysis. The sera 
for SE infected chickens were prepared from the chickens inoculated with SE at the age of 3 
weeks, and were weekly bled individually for this study. To the “vaccine sera”, SPF chickens 
were injected with Layermune SE at the age of 3 weeks and bled 4 weeks post injection. The 
sera were designed as vaccine sera.  
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Fig. 3. Production of specific antibodies SE cell (deflagellated) and SEp9 antigens 
(Nakagawa Y et al. Japanese report) 
(a; Antibody response to SE cell antigen, b; Antibody response to SEp9) 
Four commercial inactivated SE vaccines (Vaccine A to D) were used to inoculate five 3-
week-old SPF chickens/group to examine the responsiveness to SE cell antigen and SEp9. 
Results shown in Fig. 3A and 3B were obtained. No response was noted in unvaccinated 
chickens. The inactivated SE vaccine responded to SE cell antigen in all the chickens. 
Notably, the antibody response of the formulation with aluminum gel used as adjuvant 
rapidly increased and then decreased. On the other hand, the antibody response to SEp9 
was specific to each vaccine. However, this may have resulted from vaccine lot-variation. 
Further studies are needed to make a conclusion. Notably, there was no response to the 
formulation with aluminum gel used as adjuvant. 
When the levels of antibodies against inactivated SE vaccine-induced SE cell antigen and 
flagella were compared, as shown in Table 8. (Table 8. Detection of SE-specific antibodies by  
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Age (day) 
SE˧  SE˨ 
Mean E value±2SD Positive (%)  Mean E value±2SD Positive (%) 
125 0.66 ± 0.36 100  1.37 ± 0.76 100 
330 0.26 ± 0.18 60  0.77 ± 0.41 100 
550 0.29 ± 0.16 65  0.49 ± 0.34 100 
650 0.35 ± 0.23 65  0.47 ± 0.39 95 
n=20/group (chicken groups in a farm where molting is induced once at 450 days old) 
Table 8. Detection of SE-specific antibodies by ELISA coated with SE cell antigen (SE-I) or 
the g.m. antigen (SEp 9; SE-II) in inactivated SE-vaccinated chickens (Nakagawa Y et al. 
Japanese report) 
In this survey, 20 chickens were randomly extracted from inactivated SE (Layermune SE)-
vaccinated chickens (applied at about 80 days old). The positive rates of specific antibodies 
against serum SE-I and -II and mean antibody titer (E value) were examined in these flocks. 
As a result, the positive rates of specific antibodies against bacterial antigen (SE-I antigen) 
were 100% in 125-day-old chickens and 60% in 330-day-old chickens. Subsequently, these 
positive rates remained at the same levels. The positive rate of specific antibodies against the 
g.m. antigen (SEp9) gradually decreased, but remained at a high level of positive ratio. 
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Fig. 4. Detection of specific antibodies in sera against SE cell antigen and SEp9 on oral SE 
administration to field white leghorn chickens (Mizumoto N et al. 2004) 
SE was orally administered to 500-day-old laying chickens. Specific antibodies against SE 
bacterial antigen were produced in the blood. However, no specific antibody against SEp9 was 
produced. Specific antibodies were similarly detected in yolks. (The dashed line indicates an 
antibody level against SEp9, and the solid line indicates an antibody level against an SE cell 
antigen.) The symbol of closed circles means the antibody level in sera obtained from 
inoculated chickens. The open circle means the ones from not-inoculated chickens. The yolk 
antibody responses obtained from same birds were shown similar pattern as this figure.  
ELISA coated with SE cell antigen (SE-I) or the g.m. antigen (SEp 9; SE-II) in inactivated SE-
vaccinated chickens), the anti-CE cell antigen antibody level was high at 120 days of age 
about 50 days after vaccination, the antibody positivity rate was 50-60% at 300 days of age 
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(220 days after vaccination), and the rate was retained thereafter. In contrast, g.m. antigen 
(SEp 9)-antibody level was maintained at a high level until 700 days of age (about 620 days 
after vaccination). An experimental inoculation with SE in SPF chickens showed similar 
response (Fig. 4. Detection of specific antibodies in sera against SE cell antigen and SEp9 on 
oral SE administration to field white leghorn chickens). This tendency of the presence of 
specific antibody in egg yolk was observed (date not shown).  
 
Fig. 5. Positive rates of g.m.-specific antibodies in the yolks derived from field chickens 
inoculated with the inactivated SE vaccine (Publishing elsewhere by Nakagawa Y et al. ) 
In this study, the inactivated SE vaccine (Layermune SE) was used to inoculate about 80-
day-old chickens in six farms. Ten eggs were randomly collected once in two months from 
150-700-day-old chickens of each farm. Mean antibody titers (positive: ≥ 0.1 E values) 
against the g.m. antigen (SEp9) in yolks were determined. These chickens were giving an 
induced molting for about 40 days after day 450. During this period, eggs were not sampled. 
The determination with specific antibody to g.m. antigen was done according to the method 
described by Mizumoto N et al. 2004.  
The mean positive rate of the farms was about 88%. The positive rates were above 80% in all 
the farms. Thus, about 700-day-old chickens carried antibodies against SEp9. Antibodies 
against SEp9 markedly decreased the number of SE isolates in the gastrointestinal tract). In 
addition, antibodies against SEp9 inhibited SE isolation from eggs in the report. Proper 
vaccination prevented SE infection for a long time. 
Thus, specific antibodies remained in chickens inoculated with the inactivated SE vaccine, 
even after molting was induced once, as examined by SEp9-coated ELISA. The specific 
antibodies could be detected also in yolks. 
3.5 Immunogenicity of SEp 9  
A high specific antibody production level was noted in antibodies against a flagellar 
component, Fli C, in inactivated SE vaccine-treated chickens, as described above. The SE-
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specific region in Fli C is g.m. antigen (SEp 9), and the antigen was assumed to be effective 
as the antigenic site of inactivated SE vaccine (Toyota-Hanatani Y et al. 2008, and b)Toyota-
Hanatani Y et al. 2009), for which we prepared SEp 9 antigen by genetic engineering and 
investigated the efficacy of SEp 9 vaccine. Since no international method (challenge test 
model) has been established for efficacy evaluation of inactivated SE vaccine, we analyzed 
tissue reactions at the vaccine administration site in vaccinated chickens.  
   
   
 
Fig. 6. Histological reactions at the inoculation with f the inactivated SE vaccine or the g.m 
site of Fli C (b)Toyota-Hanatani H et al. 2008) 
We investigated a kinetic of histological reactions at the inoculation site of commercial 
inactivated SE vaccine or SEp 9 antigen. In the inoculation site (7a) at one week post 
vaccination (wpv), many histocytes were infiltrating, and hyperplastic connective issues are 
 
a 
 
b 
 
a 
 
a 
 
b 
a) b) 
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e) 
 
b 
 
a 
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shown (arrow a). However, tissue images, such as oil cyst, were not observed. In (7b) at 
2wpv, necrosis (arrow a), surrounded by granulomatous structures (arrow b), was observed 
in the middle of inflammatory response. Polynuclear cells appeared in some granulomatous 
structures. Oil cyst was also observed. These images indicate that the antigen and oil 
ingredients were actively excluded from the vaccine, suggesting the establishment of 
specific immunity. At 4 wpv (7c), severe necrosis at 2 weeks became smaller, and the 
inflammatory response resolved (arrow a). In addition, peripheral lymphoid node structures 
(arrow b) appeared near the disappearing necrosis, suggesting active antibody production. 
At 6 wpv (7d), hyperplastic connective tissues also disappeared. Of the tissue reactions in 
the vaccination site, the characteristic responses during specific immune reaction are the 
emergence of polynuclear, which surrounded the granulomatous structure, and peripheral 
lymphoid node like structure. Thus, the inoculation site of SEp9 antigen was histologically 
examined at four weeks. As shown in Figure 7e, a lymphoid node like structure (arrow a) 
and a small number of polynuclear cells (arrow b) appeared in the SEp9 inoculation site. 
Thus, we concluded that SEp9 could induce specific immunity in chickens. 
Materials and Methods; A commercial inactivated SE vaccine was injected and weekly taken 
tissue sample at the injected site, and then fixed and stained as usual (HE staining, X50). 
The general time course of histological changes at the inoculation site with inactivated SE 
vaccine (oil-adjuvant-type) is shown in Fig. 6 (Histological reactions at the inoculation with f 
the inactivated SE vaccine or the g.m site of Fli C); nonspecific inflammation characterized 
by marked monocyte infiltration was noted after 1 week, and perivascular granulomatous 
changes were noted at 2 weeks including the appearance of multinucleated giant cells. At 3 
weeks after vaccination, lymphocyte clustering showing a lymph node-like structure, 
considered to be an antibody production site, was noted. These reactions then slowly 
disappeared. In granulomatous changes accompanied by multinucleated giant cell 
infiltration observed after 2 weeks, cellular reactions of delayed hypersensitivity were noted 
(Table10. Characteristics of histological lesions at the inoculation site in the chicken applied 
with commercial SE vaccine (4wpi)). The tissue reactions at the SEp 9-administered site were 
similar to those induced by commercial inactivated SE vaccine, confirming anti-SEp 9-
specific antibody production (Table 11 Production of specific antibodies in chickens 
inoculated with the inactivated SE vaccine or the g.m. site of Fli C). 
When SEp 9-treated and non-treated chickens were orally challenged with SE, 
gastrointestinal SE was significantly decreased in the SEp 9-treated group compared to that 
in the non-vaccinated group, and the number of isolated bacteria was decreased similarly to 
that in the commercial inactivated SE vaccine-treated group (Fig. 7. Challenge test in 
chickens inoculated with the inactivated SE vaccine or the g.m site of Fli C). Although it is 
not clarified why the specific immunity induced by SEp 9 injection in chickens is able to 
reduce SE colonization in gastrointestinal organs, we have suspected that the induced 
immunity may affect SE yielding lower colonization ability SE. For example, the amount of a 
fibrin molecular, 21 kDa polypeptide, might be reduced on surface resulting from the 
induced specific immunity without SE-proliferation reduction. This is because the isolation 
level at 1 week post challenge in Fig. 7 (Challenge test in chickens inoculated with the 
inactivated SE vaccine or the g.m site of Fli C) does not show different bacterial level 
between SEp 9 injection and non-injection groups, even though statistical difference is 
observed. To this point, we will attempt to further clarify the mechanisms of lower SE-
colonization in SEp 9-injected birds.  
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weeks post challenge (wpc) 
Fig. 7. Challenge test in chickens inoculated with the inactivated SE vaccine or the g.m site 
of Fli C (Toyota-Hanatani Y et al. 2009) 
SEp9 induced specific immunity. Subsequently, a challenge test was conducted in SEp9-
inoculated chickens. The results are shown in this figure. When buffer alone was used for 
inoculation, the number of SE isolates did not decrease, but remained constant. The number 
of SE isolates decreased in chickens, inoculated with a commercial inactivated SE vaccine or 
SEp9, with aging. 
Material and Methods; a buffered saline, SEp 9 and Layermune SE were twice-injected with 
mixture with an oil adjuvant, respectively. Four weeks post injection from final application, 
those chickens were orally challenged with SE Y 24 strain, and SE isolation was performed 
from intestinal samples.  
Type of 
Bird 
Type of 
Vaccine 
Vaccination Age 
Route of 
Administration 
Program Advantages 
Breeders Live  
 
 
Killed 
1 day old 
7 Weeks old 
 
12-14 Weeks of 
Age 
18- 20 Weeks of 
Age 
Coarse Spray  
Drinking Water 
 
Subcutaneous 
Subcutaneous 
Broad Protection 
Selective Competitive 
Exclusion 
Strong Maternal 
Immunity 
Layers Live  
 
 
Killed 
1 day old 
7 Weeks old 
 
10-12 Weeks of 
Age 
Coarse Spray  
Drinking Water 
 
Subcutaneous 
Broad Protection 
Selective Competitive 
Exclusion 
Strong Immunity 
Broilers Live 1 Day old Coarse 
Spray or 
Drinking Water 
Coarse Spray or 
Drinking Water 
Strong Immunity 
Table 9. Recommended Salmonella vaccination programs in poultry. 
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Indicator 
No. 
Activation result of 
Characteristics in 
histological observations 
Immunological 
properties 
1 Cellular immunity 
Granular formation 
(lumps) with epithelioid 
cells 
Type 4 
hypersensitivity  
(Pellertier M et al. 
1984. 
Uthoaisangssok S et 
al. 2002)   
2 Humoral immunity 
Perivascular accumulation 
with lymphocytes 
Activated B-
lymphocytes 
3 
Non-specific 
immunity 
Hyperplastic connective 
tissue, infiltration of non-
specific immune cells 
Early or late non-
specific immune 
reaction 
Table 10. Characteristics of histological lesions at the inoculation site in the chicken applied 
with commercial SE vaccine (4wpi) (supplementary data by Toyota-Hanatani Y et al. 2008). 
This table shows three categories of reactions characteristic of tissue images on inoculation 
of a commercial inactivated SE vaccine: (1) cellular immunity, (2) hormonal immunity, and 
(3) nonspecific reaction. All the above reactions were observed in SEp9-inoculated chickens 
at 4 weeks. Supplementary data from other studies by Toyota-Hanatani Y et al. were also 
discussed in this table. 
Granulomatous reaction, observed at 2-4 weeks after inoculation of the inactivated SE 
vaccine, was considered to be the same tissue reaction as tuberculin reaction. We considered 
it to be cellular type IV (delayed) hypersensitive reaction. This might be a process of 
developing cellular immunity. 
 
Immunizing antigen Tested chickens 
Production of antibodies against g.m. 
(SEp 9) 
Antibody positive 
conversion 
Mean value in 
ELISA 
g.m.(SEp 9) antigen 4 4 0.84 
De-flagellated SE 
antigen 
4 0 0.00 
Buffer 4 0 0.00 
Inactivated SE vaccine 4 4 0.83 
Table 11. Production of specific antibodies in chickens inoculated with the inactivated SE 
vaccine or the g.m. site of Fli C (supplementary data by Toyota-Hanatani Y et al. 2008) 
This table shows specific humoral immunity induced by the g.m. antigen site (SEp9). As 
shown in the table, specific antibodies were produced when SEp9 was used to inoculate 
chickens with adjuvant. However, no specific antibodies against SEp9 were produced when 
SE cell antigen was used. Importantly, the g.m. antigen site has high immune induction 
capacity in chickens because a small amount of antigen (100 μg/bird; about 30 μg/bird of 
not involving GST) induces specific immunity. 
In another study where SEp9 in buffer was used to inoculate chickens (un-published data), 
specific antibodies were produced. Thus, specific immunity can be induced even without 
adjuvant. 
Materials and Method; See Fig. 7 
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3.6 The details of attenuated live Salmonella vaccines for poultry 
The first live Salmonella vaccine for poultry was a Salmonella enterica Serovar Gallinarum 
(SG) developed in the early 1950’s (Williams SH.et al. 1956). This attenuated SG rough strain 
called 9R has been used in many countries around the world for the control of fowl typhoid. 
However, interference with official Salmonella control and eradication programs using 
serological methods has limited the wider use of this attenuated strain in addition to 
scattered field reports of excessive attenuation and reversion to virulence. The development 
of paratyphoid live attenuated Salmonella vaccines is an advancement and reinforcement to 
the use of inactivated vaccines for Salmonella control programs in the poultry industry. 
These new attenuated live Salmonella vaccines elicit cell-mediated, mucosal and humoral 
immune responses (Gomez-Duarte. et al. 1999, Roy Curtiss R 3rd et al. 1996, Kulkarni KK et 
al. 2008, Ashraf S et al. 2011). In addition, new recombinant DNA technology permits the 
expression in Salmonella serovar strains of protective antigens from unrelated bacterial, viral 
or parasitic pathogens.  
There are two common approaches which have been applied in the development of the new 
paratyphoid live Salmonella vaccines. One of them is the genetic manipulation through 
recombinant technology selecting virulence genes to be deleted in selected Salmonella 
serovars. The other approach is the manipulation of the media used for Salmonella 
propagation resulting in a metabolic drift mutation reducing the activity of essential 
enzymes and the bacterial metabolic regulatory systems resulting in slower propagation 
cycles under natural infection conditions and this prolonged generation time cause reduced 
bacterial multiplication within the host at a significant rate. Consequently, when the 
genetically or chemically attenuated Salmonella strain is administered to the birds, the 
modified bacteria lives long enough to stimulate an immune response in chickens before to 
be eliminated within few weeks after administration of the vaccine. Currently, two 
paratyphoid serovars are commercially available as live attenuated vaccines: ST and SE. 
It is considered that the genetic deletion of selected virulent genes induced a more 
attenuated recombinant Salmonella serovar strains compared with the chemically induced 
metabolic mutants, which still have residual enzymatic activity and more invasivity 
inducing a stronger immune response.  
Epidemiological markers (Specific antibiotic resistance or sensitivity patterns) are included in 
the development process of these live vaccines to be able to differentiate the new construct or 
mutant from similar wild bacterial serovars in case of a field combined infection.   
The field use of these new live attenuated Salmonella vaccines has advantages and precautions 
to observe when administered to the chickens. The advantages of these live vaccines are: mass 
administration, different routes of administration (Drinking water, coarse spray), selective 
competitive exclusion and broader spectrum of immunity. Among the precautions to be 
observed are: Not compatible with antimicrobials, no water chlorination when administered in 
the drinking water, careful handling by the operator to protect the worker from self-infection. 
Different recommendations on the use of the attenuated live Salmonella vaccines may be found 
in the literature to obtain the best protection against field challenge in a specific environment. 
Short duration of immunity of the live attenuated vaccines may require 2 to 3 applications 
every 6 to 10 weeks to obtain a more solid protection. The combined administration of live and 
inactivated Salmonella vaccines provides broader and long lasting immunity, especially in 
breeders to transfer strong maternal immunity to the progeny. (Table 9. Recommended 
Salmonella vaccination programs in poultry). 
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3.7 SE vaccine in the future 
The current live and inactivated SE vaccines have advantages and disadvantages. Live 
vaccine is readily administrable to newborn chicks, but inactivated SE vaccine cannot be 
administered before 3 weeks of age. The detail potency mechanisms with live vaccine has 
not been clarified yet, and concerns over causing public health problems are always present: 
the possibility of back mutation of the vaccine production strains of SE and ST (such as 
reversal of pathogenicity) or mutation to a pathogenic strain cannot be completely ruled out, 
and, accordingly, live vaccine is not applicable for laying chickens as described above. 
Currently, inactivated SE vaccine is manufactured using the whole cell body containing 
endotoxin, which may induce stress in chickens, although this is slight.  
To overcome these problems, the development of a subunit or vector vaccine comprised of 
active components of SE is awaited, and many researchers may have started research and 
development.  
4. Marked usefulness of inactivated SE vaccine administration to flocks for 
reducing the human health risk  
4.1 Reduction of SE contamination risk of chicken eggs by inactivated SE vaccine  
We have surveyed the reduction of the SE contamination risk of chicken eggs by employing 
inactivated SE vaccine on field layer farms for a prolonged period. Herein, we report the 
study results.  
Four-year surveys were performed on 4 field layer farms (a total of 2,300,000 chickens 
maintained in 37 hen-houses). Records of SE isolation from liquid eggs were analyzed. Some 
chickens in these layer farms were treated with inactivated SE vaccine as a trial before 
analysis, and all chickens were vaccinated in the 4th year of analysis.  
The mean numbers of SE isolated from liquid eggs (MPN/100 mL) in the vaccinated and 
non-vaccinated groups were 2.5±0.1 and 674.8±162.9, respectively, and the isolation 
frequencies were 2.45 and 25%, respectively, showing that the isolation frequency was 
reduced to 1/10 in the vaccinated group. In addition, no SE was isolated after vaccination of 
all chickens in the 4th year (0 of 257 samples), as described above.  
It was clarified that the use of inactivated SE vaccine on layer farms significantly reduced 
the number of SE isolated from SE-contaminated eggs and the isolation frequency.  
4.2 Risk reduction by inactivated SE vaccine on risk analysis  
As described above, inactivated SE vaccine decreased the mean number of SE contaminating 
eggs as a food product to about 1/260 and the isolation frequency to 1/10. These occurred 
on SE-contaminated farms when vaccinated and non-vaccinated chickens were mixed. 
When these were simply compared with the number of orally ingested SE and the incidence 
of patients reported by the a), b)WHO and FAO-US, the incidence of SE patients in healthy 
subjects was estimated to be decreased to 1/100 or lower.  
The 4 farms involved in our study on the reduction of SE contamination of liquid eggs by 
inactivated SE vaccine were large-scale farms maintaining 350,000-950,000 chickens. These 
were windowless farms and high-level general hygiene control was also performed. 
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Accordingly, similar surveys should be conducted on floor feeding and loose housing layer 
farms, and the risk-reducing effect of SE vaccine should be investigated based on the 
combined results at national and community levels. In previous reports, the frequency of SE 
isolation from feces was reduced by about 70% in regions which applied live and 
inactivated SE vaccines individually or in combination (a),b) WHO FAO-US, 2002). The 
accumulation of individual epidemiological surveys and studies may lead to the effective 
control of SE food poisoning.  
5. Re-consideration of the mode of SE infection in chickens 
5.1 Mode of SE infection on farms and in flocks  
Many points regarding the mode of SE infection on layer farms were unclear around 1990. 
Layer farm veterinarians referred to the mode of infection of PD (vertical infection), 
considering that SE also infects in this mode, and prepared an SE detection and monitoring 
system.  Briefly, the mode of SE infection was considered as follows: SE infects breeding 
chickens and the infection transmits to chicks through breeding eggs (eggs raised to 
chickens). Some chicks die, but latent infection occurs in survivors and these chicks grow 
and lay SE-contaminated eggs. Accordingly, they considered that the antibody test in 
breeding chickens and SE test in chicks after hatching are important, and did not attach 
greater importance to SE tests of grown chickens, especially laying hens. Moreover, they 
considered that inactivated SE vaccine is ineffective for chicks after hatching, and only 
bacteriostatics and analogous agents are effective. The Pennsylvania Egg Quality Assurance 
Project (PEQAP) of the U.S.A. actively performed field SE contamination surveys to 
investigate this hypothesis, and found several new facts, as described above (Davison S et al. 
2003, Henzler DJ et al. 1998), Hogue A et al. 1997, Lin FY et al. 1988, Stevens A et al. 1989). 
The points particularly attracting attention in the PEQAP report are a very low infection 
frequency in newborn chicks, although contamination occurred, and the absence of SE 
contamination in raising houses. However, SE contamination was observed most frequently 
after transfer to layer hen houses over 180 days of age. Even though new episodes of SE 
contamination occurred thereafter (after the laying peak), the frequency was very low.  
SE sensitivity of chickens is schematically presented based on the study results reported by 
PEQAP and our experience in Fig. 8 (Age-dependent susceptibility of chickens against SE 
colonization). Chicks are very sensitive to SE infection immediately after hatching, but the 
sensitivity rapidly decreases. No clinical symptoms develop over the growth and egg-laying 
periods, but the sensitivity rises around the initiation of sexual maturation (100-120 days of 
age). In layer hen houses, the frequency of SE contamination is high, elevating the infection 
risk of chickens. It is considered that most SE infection of chickens occurs after transfer to 
layer hen houses (around 115 days of age) over the peak laying period (around 180 days of 
age). The sensitivity of layer hens slightly decreases thereafter but then slowly rises with 
aging. SE sensitivity may be enhanced when induced molting is performed during this 
period, but these chickens are already infected immediately after transfer to layer hen 
houses. Therefore, the infection rate is not actually elevated by induced molting, although 
the sensitivity is high. Considering SE sensitivity and SE control of layer flocks and 
economic damage, chicks infected immediately after hatching may be culled because they 
develop clinical symptoms. The period after transfer to layer hen houses over the egg-laying 
peak is the most important for hygienic SE control because chickens are highly sensitive to 
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SE but infection is unclear. The survey results of PEQAP well reflected this condition. 
Therefore, how hygiene control is performed during this period (after transfer to layer hen 
houses over the egg-laying peak) is important, and inactivated SE vaccine can be 
administered corresponding to this high contamination risk period.  
 
Fig. 8. Age-dependent susceptibility of chickens against SE colonization (Ohta H et al. 
presented in 2nd Symposium of the Germany-Japan veterinary association 1998) 
The susceptibility of chickens to SE infection changed with aging. Oral SE administration 
killed almost 100% of chicks before feeding. However, the death rate rapidly decreased after 
feeding. No death was usually noted in 2-3-week-old chickens even after administering 109 
FFU/bird. However, SE colonized in the intestine only for a short time. However, chickens 
became more susceptible to SE infection at around 100 days old when the reproductive 
organ developed. SE infected and colonized in the intestine for a long time in chickens of 50-
100% laying age (145-180 days old). Subsequently, chickens gradually became susceptible 
with aging. Molting chickens were more susceptible to SE infection. More susceptible 
chickens were not necessarily more vulnerable to SE infection. SE infection risks became 
higher during the stage II (145-180 days old) in the figure, causing environmental SE 
contamination condition. Thus, chickens of this age group were more susceptible to SE 
infection. These facts were taken into consideration in the measures taken in the U.S. 
5.2 SE infection of chickens  
The epidemiological mode of infection of chickens is described above, but how does it occur in 
individual chickens? Generally, SE is orally ingested. Regarding experimental SE infection of 
chickens, Bohez et al. and other study-groups actively investigated pathogenicity in young 
chickens as above mentioned, and observed that the pathogenicity manifestation mechanism 
was similar to that in mice and systemic sepsis occurred and resulted in death at a high rate. 
We also obtained similar results (data not shown). In contrast, pathogenicity was rarely 
observed and the course was asymptomatic when grown chickens and layer hens were 
infected. Weakened chickens were observed in very rare cases, but the presence of other 
factors, such as stress, is generally considered for these cases, and SE infection alone is 
Days of age
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considered to induce no morbidity. It has been considered most SE strains are not actually 
pathogenic for chickens. Therefore, it is unclear what roles are played in chickens by the genes, 
components, and molecules reported to exhibit pathogenicity in mice.  
However, unlike other Salmonella species, such as ST, SE infection shows high tropism for 
intestinal and reproductive organ epithelial cells in chickens, and the colonization rate in the 
chicken intestine is high (Mizumoto N et al. 2005, Okamura M et al. 2007). Regarding 
tropism, there has been no report on differences in tropism for epithelial cells of SE and 
other Salmonella species in other animal species, but SE shows high species specificity for 
chickens. When the oviduct surface was contacted and colonized by various Salmonella 
species, the number of colonizing bacteria of SE strains was the highest and the number 
decreased in the other of S. Agona, S. Typhimurium, S. Heidelberg, S. Harder, S. infantis, 
and S. Montevideo. The high tropism of SE for chickens is an interesting study subject. For 
example, if SE-contaminated chicken eggs serve as the main cause of SE food poisoning 
resulting from the acquisition of species specificity for chickens by many currently isolated 
SE strains, this property of SE will be a major epidemiological study subject, i.e., it explains 
the sudden emergence of appearance of chicken egg-mediated SE food poisoning caused by 
SE contaminating chicken farms in the 1980s.  
6. Proposal for food safety based on the history of emergence and decline of 
SE food poisoning  
We selected 2 topics concerning chickens and SE infection in this chapter. One was the 
usefulness of inactivated SE vaccine administration to chickens to reduce the public health 
risk. The other was the introduction of some of our studies on SE infection of chickens. In 
the first topic, the history was described in some detail because a description of the historical 
background is necessary to understand why we wanted to describe the history of the 
emergence of chicken egg-induced food poisoning. In the 1980s, the production, 
distribution, and consumption of food products and materials became global. Safety 
standards became necessary for mass production, international distribution, and the selling 
of food products and materials, with which SE food poisoning occurred and rapidly spread 
in Western countries and then declined. However, this declined incidence has recently 
tended to slightly re-increase in some countries, suggesting that it is time to review SE 
control from the basics. Together with the history of overcoming the BSE problem of beef, 
the history of emergence and control of SE food poisoning contributes to establishing the 
concept of ‘risk analysis of health damage by foods’.  
In the control of food poisoning before 1980, hygienic measures were mainly taken in the 
steps after cooking, but analysis of SE-contaminated chicken eggs led to a new concept of 
food poisoning control: SE infection of chickens should be prevented although no clinical 
symptoms develop in chickens excluding chicks immediately after hatching. The problem of 
food poisoning seems to widely extend over the world. This is of course due to large-scale 
distribution and consumption of food products and materials, but it may also be due to 
failure of inheriting food culture in countries throughout the world. Previously, sensory 
elimination of problematic food products and materials was performed in each home as 
‘food culture’, but this may not have been passed on in modern society in many countries. 
Studies on food poisoning are required to closely investigate the safety of the globalized 
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production, distribution, and consumption of food products and materials. These 
worldwide changes in food culture are a background to the emergence and decline of SE-
contaminated chicken egg-induced food poisoning.  
A large part of the text was also devoted to the usefulness of inactivated SE vaccine in this 
chapter. The first vaccine approved by the US government does not completely stop SE 
proliferation in the gastrointestine after SE challenge, and the bacterial count rather 
increases transiently. The previous concept of vaccine for chicken diseases was the 
inhibition of clinical symptoms and bacterial proliferation after challenging the pathogen, 
but SE infection does not induce clinical symptoms in chickens excluding chicks 
immediately after hatching. In other words, inactivated SE vaccine is administered for 
asymptomatic SE infection, and stress load of vaccination gives no advantage to farms. The 
use of inactivated SE vaccine was initiated in response to demands from consumers, to 
which layer farms had strong resistance, and the usefulness was frequently questioned. In 
this situation, we investigated the usefulness of inactivated SE vaccine.  
Our study demonstrated that inactivated SE vaccine is very useful with regard to the 
inhibition of SE-contaminated chicken egg production, unlike conventional vaccine for 
chicken diseases. Although SE temporarily proliferated in the chicken gastrointestine on the 
SE challenge test, the production of SE-contaminated chicken eggs was markedly inhibited. 
Specific immunity against flagellar components plays a central role in the inhibition, and, 
particularly, specific immunity against g.m. antigen is assumed to play a major role. 
Unfortunately, the mechanism of the effect of flagellar component-specific immunity has not 
been clarified, and so remains to be investigated.  
Reportedly, the current inactivated SE vaccine may induce stress in some cases. The 
development of vector vaccine with the insertion of flagellar components inducing no stress 
is underway, and may be realized in the near future.  
Some of our study results on SE infectious disease in chickens were introduced in this 
chapter. SE infection of chickens may be opportunistic infection, unlike infections of mice 
and humans. However, SE infection of chickens was not regarded as opportunistic infection 
in previous studies. SE infection of chickens has been investigated employing the mode of 
PD infection or partially employing the mode of SE infection in mice and humans as a 
model, but we have been considering that it is appropriate to basically regard Salmonella-
induced infectious disease as ‘opportunistic infection’ or less pathogenic ‘indigenous 
bacteria’. Although it causes food poisoning in humans and may result in death, it is very 
rarely fatal in chickens. For fatal cases, other factors may be the major cause, such as hot 
conditions in summer. SE infection causes no damage to chickens, but there is no doubt that 
SE-contaminated chicken eggs cause food poisoning in humans, although the mode of SE 
infection in chickens cannot be fully explained.  
We attempted to describe live SE vaccine. However, I could not draw the efficacy of the live 
vaccine for the applied flocks in their whole the life.  
Responses of SE to stimulation by chickens were confirmed as the lacy phase changed to the 
colonial phase when the bacteria entered the intestine, but other responses are slightly 
unclear. In our study, marked colonization (tropism) of the reproductive organs by SE was 
noted, compared to that by other Salmonella species, but enumeration of these facts will not 
lead to studies in the future. Thus, we selected 2 topics in this field as study subjects 
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(working hypotheses). Various conversions occur in SE and these are important to evade the 
chicken’s immune system and become indigenous. We selected these conversions as one 
topic. The other is the colonization mechanism of SE on layer farms which should be 
deduced based on the history. The colonization may have resulted from the facts that 
flagellar antigens are not expressed in chickens and chickens do not respond to the fimbrial 
components. These two mechanisms have been well-known for a long time, but it may be 
essential to analyze the mode of SE infection of chickens. SE infection of chickens is a never-
ending study area.  
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